GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fresh Tracks Therapeutics Inc (FRA:VCC) » Definitions » Shiller PE Ratio

Fresh Tracks Therapeutics (FRA:VCC) Shiller PE Ratio : (As of Jun. 05, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Fresh Tracks Therapeutics Shiller PE Ratio?

Note: If the price history is too short, we do not calculate current Shiller PE for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Fresh Tracks Therapeutics Shiller PE Ratio Historical Data

The historical data trend for Fresh Tracks Therapeutics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresh Tracks Therapeutics Shiller PE Ratio Chart

Fresh Tracks Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Fresh Tracks Therapeutics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Fresh Tracks Therapeutics's Shiller PE Ratio

For the Biotechnology subindustry, Fresh Tracks Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresh Tracks Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fresh Tracks Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Fresh Tracks Therapeutics's Shiller PE Ratio falls into.



Fresh Tracks Therapeutics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Fresh Tracks Therapeutics's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Fresh Tracks Therapeutics's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0/129.4194*129.4194
=0.000

Current CPI (Dec. 2023) = 129.4194.

Fresh Tracks Therapeutics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -91.098 99.695 -118.260
201406 -115.920 100.560 -149.188
201409 -122.220 100.428 -157.503
201412 -127.732 99.070 -166.862
201503 -116.424 99.621 -151.248
201506 -84.200 100.684 -108.231
201509 -8.420 100.392 -10.855
201512 -75.184 99.792 -97.505
201603 -73.546 100.470 -94.737
201606 -39.249 101.688 -49.953
201609 -67.360 101.861 -85.584
201612 -74.655 101.863 -94.851
201703 -73.631 102.862 -92.641
201706 -84.105 103.349 -105.321
201709 -71.357 104.136 -88.682
201712 -55.897 104.011 -69.552
201803 -74.085 105.290 -91.064
201806 -59.321 106.317 -72.211
201809 -18.897 106.507 -22.962
201812 -47.071 105.998 -57.472
201903 98.766 107.251 119.181
201906 -30.665 108.070 -36.723
201909 -67.419 108.329 -80.544
201912 -55.890 108.420 -66.715
202003 -18.326 108.902 -21.779
202006 -17.183 108.767 -20.446
202009 -5.731 109.815 -6.754
202012 -5.548 109.897 -6.534
202103 -5.670 111.754 -6.566
202106 -6.051 114.631 -6.832
202109 -6.078 115.734 -6.797
202112 -2.390 117.630 -2.630
202203 -3.223 121.301 -3.439
202206 -0.407 125.017 -0.421
202209 -2.091 125.227 -2.161
202212 -1.416 125.222 -1.463
202303 -1.065 127.348 -1.082
202306 -0.360 128.729 -0.362
202309 0.300 129.860 0.299
202312 0.000 129.419 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Fresh Tracks Therapeutics  (FRA:VCC) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Fresh Tracks Therapeutics Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Fresh Tracks Therapeutics's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresh Tracks Therapeutics (FRA:VCC) Business Description

Traded in Other Exchanges
Address
5777 Central Avenue, Suite 102, Boulder, CO, USA, 80301
Fresh Tracks Therapeutics Inc is a clinical-stage pharmaceutical company striving to transform patient lives through the development of innovative and differentiated prescription therapeutics.

Fresh Tracks Therapeutics (FRA:VCC) Headlines

No Headlines